secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2022-04-11T23:59:59+00:00
Accession:  0001193125-22-101650
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics director Thomas O. Daniel not standing for re-election at 2022 Annual Meeting
--------------------------------------------------------------------------------

- Thomas O. Daniel, Ph.D., notified the Board he will not stand for re-election as a Class II director at the 2022 Annual Meeting.
- His departure is effective at the conclusion of the Annual Meeting; no reason given other than not standing for re-election.
- No disagreement with the Company's operations, policies, or practices.
- Dr. Daniel served on the Board and any committees; no replacement named yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/0001193125-22-101650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/d334496d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-101650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer